In summary, ACVR1 mutations elicit a dependency of downstream signalling in DIPG cells than can be inhibited by single agents of multiple chemotypes of inhibitor compounds which penetrate orthotopic tumours at concentrations that produce cell death and survival benefit in orthotopic mouse models as single agents at well-tolerated dosages. The gene discussed is ACVR1; the disease is neoplasm.